Insider Transactions Reported by 16 Insiders of Immuneering Corp

Symbol
IMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 Main Street, Second Floor, Cambridge, MA

Insiders trading volume in the past year

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Benjamin J. Zeskind PRESIDENT AND CEO, Director, 10%+ Owner $9.93M +$85K +0.86% Jul 1, 2025
Peter Feinberg Director $9.06M +$202K +2.28% Oct 3, 2025
Cormorant Asset Management, LP 10%+ Owner $8.6M Apr 1, 2024
Brett Matthew Hall Chief Scientific Officer $534K +$34.6K +6.93% Sep 15, 2025
Thomas J. Schall Director $194K +$124K +178% Jun 27, 2025
Mallory Morales Chief Accounting Officer $176K +$1.92K +1.1% Oct 1, 2025
Leah R. Neufeld Chief People Officer $149K +$7.6K +5.38% Oct 1, 2025
Michael Bookman Chief Legal Officer, Secretary $33.3K +$6.97K +26.5% Oct 1, 2025
Biren Amin Cfo, Treasurer $23.8K May 12, 2022
Diana Hausman Director $19.9K +$19.9K Jul 2, 2025
Harold E. Brakewood Chief Business Officer $14.7K +$4.8K +48.7% Jun 20, 2025
Igor Matushansky Chief Medical Officer Mar 21, 2025
Ann E. Berman Director Jun 13, 2025
Carpenter Robert J Director Jun 13, 2025
Scott Barrett Chief Medical Officer Feb 15, 2023
Laurie Keating Director Jun 13, 2025

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.